Name | Number of supported studies | Average coverage | |
---|---|---|---|
goblet cell | 6 studies | 38% ± 19% | |
respiratory goblet cell | 3 studies | 27% ± 13% |
Insufficient scRNA-seq data for expression of CRACR2A at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
intestine | 99% | 902.95 | 953 / 966 | 90% | 5.36 | 476 / 527 |
prostate | 99% | 1050.89 | 243 / 245 | 85% | 5.89 | 426 / 502 |
breast | 99% | 450.28 | 453 / 459 | 85% | 4.03 | 952 / 1118 |
pancreas | 99% | 357.92 | 325 / 328 | 79% | 2.70 | 140 / 178 |
bladder | 95% | 351.86 | 20 / 21 | 78% | 2.79 | 391 / 504 |
lung | 99% | 380.80 | 575 / 578 | 71% | 2.02 | 815 / 1155 |
stomach | 82% | 181.01 | 293 / 359 | 85% | 4.00 | 242 / 286 |
esophagus | 70% | 123.39 | 1010 / 1445 | 85% | 3.24 | 155 / 183 |
skin | 94% | 774.30 | 1696 / 1809 | 51% | 1.73 | 241 / 472 |
thymus | 96% | 214.46 | 630 / 653 | 44% | 1.36 | 269 / 605 |
uterus | 93% | 169.47 | 158 / 170 | 45% | 1.16 | 207 / 459 |
ovary | 95% | 212.22 | 171 / 180 | 6% | 0.11 | 27 / 430 |
lymph node | 0% | 0 | 0 / 0 | 100% | 3.00 | 29 / 29 |
spleen | 100% | 831.04 | 241 / 241 | 0% | 0 | 0 / 0 |
adipose | 100% | 291.75 | 1200 / 1204 | 0% | 0 | 0 / 0 |
peripheral blood | 98% | 649.38 | 906 / 929 | 0% | 0 | 0 / 0 |
heart | 93% | 238.37 | 804 / 861 | 0% | 0 | 0 / 0 |
kidney | 38% | 67.28 | 34 / 89 | 49% | 0.96 | 440 / 901 |
liver | 46% | 59.17 | 103 / 226 | 15% | 0.38 | 59 / 406 |
adrenal gland | 54% | 66.87 | 140 / 258 | 6% | 0.10 | 13 / 230 |
tonsil | 0% | 0 | 0 / 0 | 56% | 1.00 | 25 / 45 |
blood vessel | 42% | 64.51 | 558 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 36% | 0.75 | 29 / 80 |
muscle | 33% | 42.34 | 264 / 803 | 0% | 0 | 0 / 0 |
brain | 19% | 22.17 | 514 / 2642 | 5% | 0.07 | 32 / 705 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0032237 | Biological process | activation of store-operated calcium channel activity |
GO_0002250 | Biological process | adaptive immune response |
GO_0051928 | Biological process | positive regulation of calcium ion transport |
GO_0002115 | Biological process | store-operated calcium entry |
GO_0005815 | Cellular component | microtubule organizing center |
GO_0000139 | Cellular component | Golgi membrane |
GO_0005576 | Cellular component | extracellular region |
GO_0016020 | Cellular component | membrane |
GO_0005886 | Cellular component | plasma membrane |
GO_0035580 | Cellular component | specific granule lumen |
GO_0005737 | Cellular component | cytoplasm |
GO_0005525 | Molecular function | GTP binding |
GO_0005509 | Molecular function | calcium ion binding |
GO_0005515 | Molecular function | protein binding |
GO_0003924 | Molecular function | GTPase activity |
Gene name | CRACR2A |
Protein name | EF-hand calcium-binding domain-containing protein 4B (Calcium release-activated calcium channel regulator 2A) (CRAC channel regulator 2A) (Calcium release-activated channel regulator 2A) (Ras-related protein Rab-46) Calcium release activated channel regulator 2A |
Synonyms | EFCAB4B RAB46 |
Description | FUNCTION: [Isoform 1]: Ca(2+)-binding protein that plays a key role in store-operated Ca(2+) entry (SOCE) in T-cells by regulating CRAC channel activation. Acts as a cytoplasmic calcium-sensor that facilitates the clustering of ORAI1 and STIM1 at the junctional regions between the plasma membrane and the endoplasmic reticulum upon low Ca(2+) concentration. It thereby regulates CRAC channel activation, including translocation and clustering of ORAI1 and STIM1. Upon increase of cytoplasmic Ca(2+) resulting from opening of CRAC channels, dissociates from ORAI1 and STIM1, thereby destabilizing the ORAI1-STIM1 complex. .; FUNCTION: [Isoform 2]: Rab GTPase that mediates the trafficking of Weibel-Palade bodies (WPBs) to microtubule organizing center (MTOC) in endothelial cells in response to acute inflammatory stimuli . During histamine (but not thrombin) stimulation of endothelial cells, the dynein-bound form induces retrograde transport of a subset of WPBs along microtubules to the MTOC in a Ca(2+)-independent manner and its GTPase activity is essential for this function . Ca(2+)-regulated dynein adapter protein that activates dynein-mediated transport and dynein-dynactin motility on microtubules and regulates endosomal trafficking of CD47 . Acts as an intracellular signaling module bridging two important T-cell receptor (TCR) signaling pathways, Ca(2+)-NFAT and JNK, to affect T-cell activation . In resting T-cells, is predominantly localized near TGN network in a GTP-bound form, upon TCR stimulation, localizes at the immunological synapse via interaction with VAV1 to activate downstream Ca(2+)-NFAT and JNK signaling pathways . Plays a role in T-helper 1 (Th1) cell differentiation and T-helper 17 (Th17) cell effector function . Plays a role in store-operated Ca(2+) entry (SOCE) in T-cells by regulating CRAC channel activation . . |
Accessions | H0YFI5 ENST00000440314.7 [Q9BSW2-2] ENST00000252322.1 [Q9BSW2-1] Q9BSW2 ENST00000535292.1 ENST00000333750.9 H7BXT2 |